Investment Summary |
|
|---|---|
| Date | 2007-10-03 |
| Target | Zenotech Laboratories |
| Sector | Life Science |
| Investor(s) | Ranbaxy Laboratories |
| Deal Type | Stake Purchase |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 1961 |
| Sector | Life Science |
| Employees | 15,300 |
Ranbaxy Limited is an integrated, research based, international pharmaceutical company producing a wide range of quality, affordable generic medicines, trusted by healthcare professionals and patients across geographies. Ranbaxy’s continued focus on R&D has resulted in several approvals in developed and emerging 4 markets, many of which incorporate proprietary Novel Drug Delivery Systems and technologies developed at its own labs.
| DEAL STATS | # |
|---|---|
| Overall | 2 of 2 |
| Sector: Life Science M&A | 2 of 2 |
| Type: Stake Purchase M&A Deals | 1 of 1 |
| Country: India M&A | 1 of 1 |
| Year: 2007 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2006-03-29 |
Terapia SA
Cluj-Napoca, Romania Terapia, then second-largest pharmaceuticals manufacturer in Romania, was a household name with an 80-year heritage. |
Buy | $324M |
